-
1
OGM shows high sensitivity (96%) and specificity (100%) for acute leukemia.
-
2
Identified 640 variants, surpassing karyotyping and FISH results.
-
3
OGM can reveal clinically relevant alterations that influence diagnosis.
-
4
Implemented in November 2023 for adult acute leukemia.
-
5
Turnaround time for OGM is longer than traditional methods (9 days for preliminary reports).
-
6
Enhanced diagnostic re-classification was particularly noted in B-cell acute lymphoblastic leukemia.
Original Source(s)
Related Content
Reducing the Impact of Climate-Induced Events on Patients and Oncology Staff
Although 2023 made headlines as the hottest year in human history,1 drawing the world closer to breaching the goals outlined in the Paris Agreement to substantially reduce global greenhouse gas emissi...
by Jo Cavallo
March 24, 2026
-
15 min
Awareness of Alcohol-Cancer Link Holds Steady Despite Omission in New U.S. Dietary Guidelines, Survey Finds
“The Surgeon General’s finding that alcohol consumption raises cancer risk gained attention. A clear, strong statement in the dietary guidelines could have amplified that impact—and helped to save liv...
March 24, 2026
-
3 min
The New Path to ADCs
Engineering payload selectivity for a better quality of life
March 24, 2026
-
11 min
